Atrial natriuretic peptide polymorphisms, hydrochlorothiazide and urinary potassium excretion

International Journal of Cardiology

Volumn 144, Issue 1, 2010, Pages 72-74

  Vormfelde, Stefan Viktor ^a   Toliat, Mohammad Reza ^b   Nürnberg, Peter ^b   Brockmöller, Jürgen ^a  

^a UNIVERSITY MEDICAL CENTER GÖTTINGEN   (Germany)

^b UNIVERSITY OF COLOGNE   (Germany)

Author keywords

Antihypertensive therapy; Atrial natriuretic peptide; Genetic polymorphism; Hydrochlorothiazide; Potassium; Thiazide diuretic

Indexed keywords

ATRIAL NATRIURETIC FACTOR; HYDROCHLOROTHIAZIDE; POTASSIUM;

ALLELE; DNA POLYMORPHISM; GENETIC ASSOCIATION; HUMAN; LETTER; POTASSIUM EXCRETION; PRIORITY JOURNAL;

EID: 77957882560     PISSN: 01675273     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijcard.2008.12.028     Document Type: Article

References (5)

1. John SW, Krege JH, and Oliver PM Genetic decreases in atrial natriuretic peptide and salt-sensitive hypertension Science 267 1995 679 681
2. Rubattu S, Bigatti G, and Evangelista A Association of atrial natriuretic peptide and type a natriuretic peptide receptor gene polymorphisms with left ventricular mass in human essential hypertension J Am Coll Cardiol 48 2006 499 505
3. Lynch AI, Boerwinkle E, and Davis BR Pharmacogenetic association of the NPPA T2238C genetic variant with cardiovascular disease outcomes in patients with hypertension JAMA 299 2008 296 307
4. Vormfelde SV, Sehrt D, Bolte D, Pahl S, Tzvetkov M, and Brockmöller J Hydrochlorothiazide efficacy and polymorphisms in ACE, ADD1 and GNB3 in healthy, male volunteers Eur J Clin Pharmacol 62 2006 195 201
5. Coats AJ Ethical authorship and publishing Int J Cardiol 131 2009 149 150